Carbon‐11 labeled irreversible inhibitors for mapping epidermal growth factor receptor tyrosine kinase (EGFR‐TK)
- 1 May 2001
- journal article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 44 (S1) , S99-S101
- https://doi.org/10.1002/jlcr.2580440134
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Tyrosine Kinase Inhibitors. 17. Irreversible Inhibitors of the Epidermal Growth Factor Receptor: 4-(Phenylamino)quinazoline- and 4-(Phenylamino)pyrido[3,2-d]pyrimidine-6-acrylamides Bearing Additional Solubilizing FunctionsJournal of Medicinal Chemistry, 2000
- In vivo evaluation of the biodistribution of 11C-labeled PD153035 in rats without and with neuroblastoma implantsLife Sciences, 1999
- Tyrosine Kinase Inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(Phenylamino)pyrido[d]pyrimidine Acrylamides as Irreversible Inhibitors of the ATP Binding Site of the Epidermal Growth Factor ReceptorJournal of Medicinal Chemistry, 1999
- Application of a novel phenylpiperazine formation reaction to the radiosynthesis of a model fluorine-18-labeled radiopharmaceutical (18FTFMPP)Nuclear Medicine and Biology, 1997
- Tyrphostins IV—Highly potent inhibitors of EGF receptor kinase. Structure-activity relationship study of 4-anilidoquinazolinesBioorganic & Medicinal Chemistry, 1996
- Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude miceInvestigational New Drugs, 1995
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995
- A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine KinaseScience, 1994
- Synthesis of no carrier added [1-11C]propenoic acid and derivativesInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1992